Key result
Treatment of peritrochanteric fractures with the PFNA II device achieved ideal implant position in 88% of cases and good to excellent functional outcomes in 62% of patients at 6 months.
Why the study?
Does PFNA II improve radiographic and functional outcomes in patients with peritrochanteric fractures?
Observational (n=25)
No
Does PFNA II improve radiographic and functional outcomes in patients with peritrochanteric fractures?
PFNA II is an effective fixation implant for unstable peritrochanteric fractures, yielding good radiological and functional outcomes despite some complications.
PFNA II yields acceptable radiographic and functional results in peritrochanteric fractures; leaves open need for RCTs versus established devices.
Background: Peritrochanteric fractures are devastating injuries involving young and adult population and needs surgical fixation. But there are many complications related to fixation devices & quality of bone. In view of this surgical management of peritrochanteric fractures by other better device is taken up. Material & Method: Twenty five patients with peritrochanteric fracture were included as per inclusion & exclusion criteria. Radiographic & functional outcomes of PFNA II along with its intra & post- operative complications is evaluated. Result: Out of 25 cases there were 13 males and 12 females with age ranging from 22- 95 yrs. Mean duration of hospital stay, operative time & blood loss was 6.28±3.4 days, 54.60±11.71 min & 102.80±15.41 ml respectively. Radiologically ideal implant position in 88% cases & good/ acceptable reduction in 92 % patients was achieved. Good to excellent functional results of operated hip were seen in 62 % cases of peritrochanteric fractures. Intraoperative complications like fracture of lateral cortex & greater trochanter along with fixation of fracture in varus angulation in one case & failure to get anatomical reduction resulting in varus angulation in other case. Postoperatively two patients had deep vein thrombosis & two patients had shortening >4 CMS. Conclusion: PFNA II is very effective & good fixation implant for unstable peritrochanteric fractures.
No takes yet. Share an insight, caveat, or question.
Aviral et al. (2018) conducted an observational in Extracapsular proximal femoral fractures (peritrochanteric fractures) (n=25). Proximal femoral nail anti-rotation (PFNA II) was evaluated on Radiographic implant position and functional outcomes (modified Harris hip score). Treatment of peritrochanteric fractures with the PFNA II device achieved ideal implant position in 88% of cases and good to excellent functional outcomes in 62% of patients at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: